Insilico Medicine is an AI-driven drug discovery company that uses generative AI to design novel drug molecules, identify disease targets, and predict clinical trial outcomes, with a pipeline spanning oncology, fibrosis, and immunology. It has demonstrated industry-leading speed in generating clinical candidates from concept to IND.
Category
Healthcare
Subcategory
Drug Discovery
Free Tier
Not available yet
Paid Plans
Pharma partnerships and Pharma.AI platform licensing
API Cost
Not available yet
Web App
● certified · ○ not verified
Compliance data is community-sourced and may be incomplete or out of date. Always verify certifications directly with the vendor's official trust or security page before relying on them.
Self-hostable
No
Some data-handling details aren't verified yet. Help verify this data ↗
Designing novel small molecule drug candidates with generative AIIdentifying new biological targets for disease treatmentPredicting potential drug candidates for IPF and oncologyAccelerating hit-to-lead optimization in drug discoveryPharmaceutical R&D partnerships for target-specific programs
// MORE IN DRUG DISCOVERY
HealthcareDrug Discovery
#drug discovery#machine learning
HealthcareDrug Discovery
#drug discovery#molecular modeling
HealthcareDrug Discovery
#drug discovery#knowledge graph